Latest Canadian Healthcare Market News

Page 1 of 1

Health Canada Grants Approval for CLINUVEL’s SCENESSE to Treat Rare EPP Disorder

CLINUVEL Pharmaceuticals secures Canadian marketing approval for SCENESSE®, expanding access to the only approved systemic photoprotective treatment for erythropoietic protoporphyria (EPP).

Victor Sage

13 July 2026

Top